Work from others and ongoing studies in our laboratory suggest that systemic and pelvic inflammation are critical factors for prostate cancer progression and that proinflammatory cytokines (e.g., IL-1, IL-6, IL-8, and MCP-1) can accelerate the progression of existing disease (manuscript in preparation)106–108. Here, IL1B is linked to prostate cancer.